scholarly article | Q13442814 |
P953 | full work available at URL | http://molpharm.aspetjournals.org/cgi/content/abstract/40/5/846 |
P698 | PubMed publication ID | 1658615 |
P2093 | author name string | R. P. Mason | |
V. Fischer | |||
L. Greiner | |||
R. V. Lloyd | |||
J. A. Haar | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | agranulocytosis | Q396013 |
P304 | page(s) | 846-853 | |
P577 | publication date | 1991-11-01 | |
P1433 | published in | Molecular Pharmacology | Q1943386 |
P1476 | title | Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis | |
P478 | volume | 40 |
Q38926238 | Deferiprone-Induced Agranulocytosis : A Critical Review of Five Rechallenged Cases |
Q71816832 | Does eosinophilia predict clozapine induced neutropenia? |
Q35604216 | Drug derived radicals: mediators of the side effects of anti-inflammatory drugs? |
Q41172369 | Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism |
Q34403403 | Idiosyncratic drug reactions: a mechanistic evaluation of risk factors |
Q83025440 | Interaction of clozapine and its nitrenium ion with rat D2 dopamine receptors: in vitro binding and computational study |
Q36664085 | Investigating the mechanisms of aromatic amine-induced protein free radical formation by quantitative structure-activity relationships: implications for drug-induced agranulocytosis |
Q35069583 | JL 13, an atypical antipsychotic: a preclinical review. |
Q47737546 | Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development |
Q35704333 | Possible role of free radical formation in drug-induced agranulocytosis |
Q36693011 | Restarting clozapine after neutropenia: evaluating the possibilities and practicalities |
Q56474940 | The Role of Active Metabolites in Drug Toxicity |
Q45896435 | The effects of ziprasidone, clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison |
Q44400977 | The influence of olanzapine on immune cells in patients with schizophrenia |
Q57166595 | The use of structural alerts to avoid the toxicity of pharmaceuticals |
Search more.